Oral Benign Mucous Membrane Pemphigoid: A Case Report
Benign mucous membrane pemphigoid (BMMP) is a chronic subepithelial vesiculobullous disease of the mucous membranes and, occasionally, the skin. BMMP is a disease mainly of late middle age with a slight predi- lection for women. Oral cavity is the most common site. Most patients with oral BMMP manifest desquama- tive gingivitis. The present report was aimed to describe a case of oral BMMP in 56-year-old male. The patient presented with clinical features of desquamative gingi- vitis and painful ulcers on the buccal vestibule. The diagnosis of BMMP was established on the basis of clinical, histopathologic, and immunofluorescent findings. The patient was successfully treated with systemic and topical steroids.
1. Scully C. Carrozzo M. Gandolfo S, et al. Update on mucous membrane pemphigoid - A heterogeneous immune mediated subepithelial blistering entity. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1999; 88: 56-68.
2. Williams DM. Vesiculo-bullous mucocutaneous disease: benign mucous membrane and bullous pemphigoid. J Oral Pathol Med 1990; 19: 16-23.
3. Regezi JA, Sciubba JJ. Oral Pathology. Clinical Pathologic Correlations, 2 ed. W.B. Saunders: Philadelphia: 1999:21-25.
4. Silverman S Jr. Gorsky M, Lozada-Nur F, et al. Oral mucous membrane pemphigoid: a study of sixty-five patients. Oral Surg Oral Med Oral Pathol 1986; 61: 233-7.
5. Ahmed AR, Kurgis BS, Roger RS. Cicatricial pem- phigoid. I Am Acad Dermatol 1991; 24: 987-1001.
6. Sklavounou A, Laskaris G. Childhood cicatricial pemphigoid with exclusive gingival involvement. J Oral Maxillofac Surg 1990, 19: 197-9.
7. Moy W. Kumar V, Friedman RP, et al. Cicatricial pemphigoid: a case of onset at age 5. J Periodontol 1986: 57:39-43.
8. Laskaris G, Satriano RA. Drug-induced blistering oral lesions. Clm Dermanal 1993, 11:545-50.
9. Van Joost T. Vanit Veen AJ. Drug-induced cicatricial pemphigoid and acıpaired epidermisły sis bullosa. Clin Dermaal 1993 11:521-7.
10. Nayar M, Wojnarowska F, Venning V, exal Associa tios of autoimmunity and cicatricial pemphigrid is there an immunogenetic basis J Am Acad Dermatisl 1991,25 1011-5.
11. Eversole LR. Immunopathology of oral macosal ulcerative, desquamative and balious diseases, Oral Sury Oral Med Oral Pathol 1994, 77-555-71.
12. Laskatis G. Sklavounou A. Stratigos 1. Ballous pemphigoid, cicatricial pemphignid, and pemphigus vulgaris a comparative clinical survey of 2018 caves. Oral Surg Oral Med Oral Pathol 1982:54:050-62.
13. Scully C, Porter St, The clinical spectrum of desqu mative gingivitis. Semin Catan Med Surg 1997, 16 308-15.
14. Siegel MA. Balciunas BA. Oral presentation and management of vesiculobullous dosorders. Semin Dermunal 1994: 1378-80.
15 Carbone M. Castellano S. Carrozzo M. et al. Systemic corticosteroid in the treatment of oral vesiculoerosive diseases. J Dent Res 1996, 77: 747.
16. Fine JD, Management of acquired bullous diseases. New Engl J Med 1995, 333: 1475-64.
17. Evervole Lt. Adhesion molecules and oral mucosal diseases. Oral Diseases 1996:2:185-7.
18. Shimizu H. Masunaga T. bhiko A. Autoantibodies. from patients with cicatricial pemphigoid target different sites in epidermal basement membrane. I hevest Dermatol 1995, 104: 370-3.
19. Allbritton II, Nomesari HC, Anhalt Gl. Ann-epiligrin (laminin 5) cicatricial pemphigoid. Br J Dermatol 1997: 137: 992-6.
20. Silverman S, Lozada NF. Migliorati C. Clinical efficacy of prednisone in the treatment of patients with oral inflammatory alcerative diseases: A study of 53 patients. Oral Surg Oral Med Oral Pathal 1985: 59:360-3.
21. Lozada NF, Silverman S, Migliorati C. Adverse side effects associated with prednisone in the treatment of patients with oral inflammatory ulcerative diseases. JADA 1984; 109:269-70.
22. Vincent SD, Lilly GE, Baker KA. Clinical, historic, and therapeutic features of cicatricial pemphigoid Oral Surg Oral Med Oral Pathol 1993; 76: 453-9.
23 Mutasim DF, Pele NJ. Anhalt GJ. Cicatricial pem- phigoid. Dermatol Clin 1993, 11: 499-510.